Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Investigate the effect of Bacterial Vaginosis-associated bacteria on the efficacy of Anti-HIV therapy
Infection with human immunodeficiency virus type 1 (HIV-1) remains one of the leading causes of death worldwide with young women in sub-Saharan Africa the most affected. Although pre-exposure prophylaxis (PrEP) with antiretroviral (ARV) drugs such as tenofovir (TFV) and emtricitabine have been shown...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | ENG |
| Published: |
Department of Integrative Biomedical Sciences (IBMS)
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Investigate the effect of Bacterial Vaginosis-associated bacteria on the efficacy of Anti-HIV therapy
- Investigate the effect of Bacterial Vaginosis-associated bacteria on the efficacy of Anti-HIV therapy
- The effect of bacterial vaginosis on HIV infection
- The role of bacterial vaginosis-associated sialidase on HIV-1 infection
- Characterisation of vaginal Prevotella strains from a cohort of South African adolescent girls and young women with and without bacterial women with and without bacterial vaginosis
- Diversity of vaginal microbiota associated with bacterial vaginosis and the impact on pregnancy outcomes in HIV-infected and uninfected women.
- The association between genital mycoplasmas and bacterial vaginosis in pregnant women with or without genital symptoms